[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-359426-105":59,"doc-detail-359426-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","glucocorticoid-induced-proteome-and-phosphoproteome-changes-in-breast-cancer-cell-lines","Glucocorticoid-Induced Proteome and Phosphoproteome Changes in Breast Cancer Cell Lines","","Glucocorticoids (GCs) are steroid hormones that bind the glucocorticoid receptor (GR) to trigger systemic anti-inflammatory effects, and they are often administered with chemotherapy in breast cancer. Yet GC use can also promote metastasis, motivating this study. Quantitative mass-spectrometry analyses of proteomes and phosphoproteomes in three breast cancer cell lines treated with dexamethasone (Dex) show that GR level strongly shapes Dex responses, including regulation of noncanonical transcription factors and kinases. Results indicate Dex-driven protein and phosphorylation changes tied to cytoskeletal remodeling and migration, supporting careful GC consideration and revealing potential molecular targets to reduce adverse effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/glucocorticoid-induced-proteome-and-phosphoproteome-changes-in-breast-cancer-cell-lines/359426/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/glucocorticoid-induced-proteome-and-phosphoproteome-changes-in-breast-cancer-cell-lines/359426.png","ImageObject",300,407,{"name":92,"@type":93},"Connor ","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-01","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"Why are glucocorticoids used in breast cancer therapy, and what risk do they pose?","Question",{"text":112,"@type":113},"Glucocorticoids are often coadministered with chemotherapy to reduce treatment-related side effects. The document also notes evidence that GC administration can promote metastasis in breast cancer.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How was the effect of dexamethasone (Dex) assessed in this study?",{"text":117,"@type":113},"The study used quantitative mass-spectrometry-based approaches to analyze proteome and phosphoproteome changes in three breast cancer cell lines after Dex treatment.",{"name":119,"@type":110,"acceptedAnswer":120},"What role does GR level play in the Dex-mediated response?",{"text":121,"@type":113},"The document states that the level of the glucocorticoid receptor (GR) significantly affects Dex-mediated responses across the compared cell lines.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},359426,1791136144,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},687207022233,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","This article is licensed under CC-BY-NC-ND 4.0  \n[pubs.acs.org/jpr](pubs.acs.org/jpr)  Article   \nGlucocorticoid-Induced Proteome and Phosphoproteome Changes in Breast Cancer Cell Lines  \nHayoung Cho and Jesper V. Olsen *  \n Cite This: J. Proteome Res. 2026, 25, 2110−2122  Read Online  \n\n|  |  |  |  |  |  |\n| --- | --- | --- | --- | --- | --- |\n| ACCESS   | Metrics & More |  |  Article Recommendations |  | *sı Supporting Information |\n\nABSTRACT: Glucocorticoids (GCs) are steroid hormones that bind to the glucocorticoid receptor (GR) as ligands to initiate systemic anti-inflammatory effects. GCs are commonly administered alongside chemotherapy to reduce treatment-related side effects in breast cancer patients. However, GC administration has been shown to promote metastasis in breast cancer. In this study, we used quantitative mass-spectrometry-based approaches to analyze proteome and phosphoproteome of three breast cancer cell lines following treatment of a clinically approved synthetic GC, dexamethasone (Dex). By comparing MCF7, MDA-MB-231, and MDA-MB-436 cells, we suggest that the level of GR significantly affects Dex-mediated responses. Additionally, we identify noncanonical transcription factors (TFs) and kinases that are regulated  \nby GR in different cell lines. Together, our data present Dex-induced protein modulations and modifications involving several TFsand kinases that regulate cytoskeletal remodeling and migration in breast cancer cell lines. These findings highlight the need for careful consideration of GC use in breast cancer therapy and identify potential molecular targets for mitigating adverse effects. KEYWORDS: breast cancer, metastasis, cancer cell lines, glucocorticoids, LC-MS/MS, nDIA, label-free, proteome, phosphoproteome  \n■ INTRODUCTION  \nBreast cancer is one of the most lethal types of tumors that has the highest incidence rate in female cancer patients.1 At the molecular level, breast cancer is highly heterogeneous by nature. It can be classified into four main subtypes: basal-like triple-negative breast cancer (TNBC), human epidermal growth factor receptor 2 (HER2, also known as erbB2) -positive (HER2+), luminal A, and luminal B. This is based on the expression of hormone receptors, estrogen receptor (ER), progesterone receptor (PR), a cell proliferation marker Ki67, and HER2. Somatic mutations in genes, such as BRCA1, BRCA2, and TP53, also contribute to the development and aggressiveness of breast cancer.2  \nAccording to the Surveillance, Epidemiology, and End Results (SEER) program (2014−2020), the 5-year relative survival rate for breast cancer patients remains high at 91% but sharply drops to 32% for those diagnosed with distant or metastatic breast cancer. Among 15 distant metastasis sites, the most commonly affected organs are bone, followed by the lung, liver, and brain. By subtype, luminal tumors are more prone to bone metastasis, whereas TNBC and HER2+ tumors show a preference for intestinal and brain metastases.3 Data from an ongoing PRAEGNANT breast cancer registry (NCT02338167) indicate that the BRCA1 mutation is associated with more than double the rate of brain metastasis compared with wild-type tumors.4 Similarly, a retrospective  \n© 2026 The Authors. Published by American Chemical Society  \nstudy of breast cancer patients between 2000 and 2017 found that the BRCA1 mutation increased brain metastasis in TNBC, although the overall frequency of brain metastasis was similar between carriers and noncarriers. Nonetheless, brain metastasis notably reduced survival across all breast cancer types.5 These reports highlight the need for a deeper understanding of molecular heterogeneity and its impact on treatment responses to advance the development of breast cancer clinical development.  \nTranscription factors (TFs) function as master regulators of carcinogenesis by controlling the expression of many target genes and their downstream pathways. In breast cancer, TFshave pivotal roles in facilita","cbCaigkE1mwCcsPo","https://ap.wps.com/l/cbCaigkE1mwCcsPo","pdf",6866087,13,"English","# Abstract\n# Introduction\n## Breast cancer heterogeneity and clinical burden\n## Transcription factors and nuclear receptors in metastasis\n## Glucocorticoids, GR activation, and conflicting evidence\n# Study rationale from proteomics and phosphorylation changes","[{\"question\":\"Why are glucocorticoids used in breast cancer therapy, and what risk do they pose?\",\"answer\":\"Glucocorticoids are often coadministered with chemotherapy to reduce treatment-related side effects. The document also notes evidence that GC administration can promote metastasis in breast cancer.\"},{\"question\":\"How was the effect of dexamethasone (Dex) assessed in this study?\",\"answer\":\"The study used quantitative mass-spectrometry-based approaches to analyze proteome and phosphoproteome changes in three breast cancer cell lines after Dex treatment.\"},{\"question\":\"What role does GR level play in the Dex-mediated response?\",\"answer\":\"The document states that the level of the glucocorticoid receptor (GR) significantly affects Dex-mediated responses across the compared cell lines.\"}]","Glucocorticoid-Induced Proteome and Phosphoproteome Changes in Breast Cancer Cell Lines | PDF",1790136871,33,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e0bdf9cd3c13087ed7165cf11fa5684.webp",983,1296,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/267da966e46a1ca9dd6ab8dba7c074e6.webp",982,1295,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ce11f55d53dfa8ac915b1695c904c9f1.webp",981,1293,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/800bb4ee016da20a67e9ffd5adc70f82.webp",980,1292]